Wall Street Experts
ver. ZuMIgo(08/25)
Checkpoint Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -38
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
1 |
3 |
2 |
4 |
2 |
1 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
335.6% |
-32.9% |
103.2% |
-51.3% |
-37.4% |
-74.9% |
-28.4% |
-46.4% |
-60.2% |
Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
-1031.4% |
-1429.7% |
-17979.5% |
-25850.5% |
100.0% |
100.0% |
EBIT (mln) |
-13 |
-22 |
-23 |
-37 |
-25 |
-23 |
-57 |
-58 |
-52 |
-56 |
EBIT Δ r/r |
0.0% |
67.6% |
2.8% |
61.3% |
-32.4% |
-6.6% |
144.5% |
2.8% |
-10.6% |
7.7% |
EBIT (%) |
-2240.8% |
-862.4% |
-1320.3% |
-1047.9% |
-1454.9% |
-2170.3% |
-21165.3% |
-30381.8% |
-50629.1% |
-137009.8% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
EBITDA (mln) |
-13 |
-22 |
-23 |
-37 |
-25 |
-23 |
-57 |
-54 |
-52 |
-56 |
EBITDA(%) |
-2240.5% |
-860.6% |
-1314.6% |
-1047.9% |
-1454.9% |
-2170.3% |
-21165.3% |
-28063.5% |
-50629.1% |
-137009.8% |
Podatek (mln) |
0 |
0 |
0 |
-1 |
-0 |
-0 |
-0 |
4 |
0 |
0 |
Zysk Netto (mln) |
-14 |
-22 |
-23 |
-36 |
-25 |
-23 |
-57 |
-67 |
-52 |
-56 |
Zysk netto Δ r/r |
0.0% |
61.7% |
1.0% |
60.4% |
-32.4% |
-6.6% |
146.6% |
18.2% |
-22.5% |
8.5% |
Zysk netto (%) |
-2354.6% |
-874.0% |
-1314.6% |
-1037.3% |
-1439.0% |
-2147.9% |
-21125.7% |
-34851.6% |
-50336.9% |
-137170.7% |
EPS |
-5.69 |
-10.43 |
-10.03 |
-12.74 |
-6.96 |
-4.11 |
-7.45 |
-7.57 |
-2.77 |
-1.42 |
EPS (rozwodnione) |
-5.69 |
-10.43 |
-10.03 |
-12.74 |
-6.96 |
-4.11 |
-7.45 |
-7.57 |
-2.77 |
-1.42 |
Ilośc akcji (mln) |
2 |
2 |
2 |
3 |
4 |
6 |
8 |
9 |
19 |
40 |
Ważona ilośc akcji (mln) |
2 |
2 |
2 |
3 |
4 |
6 |
8 |
9 |
19 |
40 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |